Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer
SUPPLEMENTARY MATERIALS
The interactions between Cu compound and HSA by spectrum analysis Fluorescence spectrum HSA solution (1 μM) was titrated by successive additions of the Cu(II) compound using micropipettes for all of the experiments. The fluorescence emission spectra were scanned from 300 to 420 nm after excitation at 280 nm (the maximum emission was obtained at 347). 
UV−visible spectrum
UV−visible absorption spectra were measured on a Cary 1E UV−Visible spectrophotometer in the 200−800 nm range, connected to a Haake F3 water bath, which maintained the temperature of each sample at 37°C. Measurements were performed by using 30 μM HSA and 30 μM solutions of each sample in 1 mL volumes.
Matrix-assisted laser desorption ionization time-offlight mass spectrometry (MALDI-TOF-MS) analyses
HSA protein solution (1.5 mM) was added to solutions of the Cu(II) compound in order to achieve a 4:1 metal/protein ratio and shaken for 24 h at room temperature. The samples were prepared using the dried droplet method with freshly prepared sinapinic acid [10 mg/mL in CH 3 CN/H 2 O/trifluoroacetic acid (70:29.9:0.1)] as the matrix solution. The protein sample solution (0.1 mL, series of 1:10 dilutions) was mixed on the target with the matrix solution (0.1 mL) and allowed to air-dry. The MS spectra were recorded in the m/z 30000−100000 range in a positive linear mode. 
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